2021
DOI: 10.1155/2021/1075481
|View full text |Cite
|
Sign up to set email alerts
|

lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability

Abstract: Background. Chemoresistance and tumor recurrence lead to high deaths in colorectal cancer (CRC) patients. Cancer stem cells (CSCs) contribute to these pathologic properties, but the exact mechanisms are still poorly understood. This study identified that long noncoding RNA (lncRNA) TUG1 was highly expressed in CRC stem cells and investigated its mechanism. Methods. After the CD133+/CD44+ cells with cancer stem cell (CSC) characteristics were isolated and identified by flow cytometry, lncRNA TUG1 expression was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 42 publications
0
8
0
Order By: Relevance
“…According to related studies, LncRNA TUG1, a chromatinmodifying complex located on human chromosome 22q12.2, has a high expression in vascular endothelial cells and regulates the CP and CA of oncocytes, making it a potential tumor biomarker and therapeutic target [2]. Cur-rently, a lot of research has authenticated that LncRNA TUG1 influences the malignant behavior of tumors by inhibiting miRNAs [3,4]. For instance, LncRNA TUG1 can adsorb miR-29c-3p, which enhances the malignant behavior of gastric adenocarcinoma [5].…”
Section: Introductionmentioning
confidence: 99%
“…According to related studies, LncRNA TUG1, a chromatinmodifying complex located on human chromosome 22q12.2, has a high expression in vascular endothelial cells and regulates the CP and CA of oncocytes, making it a potential tumor biomarker and therapeutic target [2]. Cur-rently, a lot of research has authenticated that LncRNA TUG1 influences the malignant behavior of tumors by inhibiting miRNAs [3,4]. For instance, LncRNA TUG1 can adsorb miR-29c-3p, which enhances the malignant behavior of gastric adenocarcinoma [5].…”
Section: Introductionmentioning
confidence: 99%
“…Sun et al. discovered that TUG1 increased chemoresistance and enhanced cancer stem cell behaviors via stabilizing GATA6 protein in colorectal cancer ( 68 ). TUG1 targeted AKT/mTOR signaling pathway via sponging miR-582-3p, which promoted ovarian cancer malignant behaviors ( 69 ).…”
Section: Lncrnas Regulate the Expression Of F-box Proteinsmentioning
confidence: 99%
“…Recent studies prove that specific ncRNAs may be the key targets in overcoming chemotherapeutic resistance. In case of the lncRNA subgroup in CRC these are for example HOTAIRM1 [ 30 ], lncRNA-cCSC1 [ 26 ], SCARNA2 [ 31 ], LINC01347 [ 32 ], HAND2-AS1 [ 33 ], lnc273–31, and lnc273–34 [ 34 ], TUG1 [ 35 ].…”
Section: Chemoresistance-associated Ncrnasmentioning
confidence: 99%
“…TUG1 is another lncRNA inducing oxaliplatin resistance in CRC stem cells, where its expression is elevated. It is proven to stabilise transcription factor GATA6 [ 35 ].…”
Section: Chemoresistance-associated Ncrnasmentioning
confidence: 99%